## Abstract To investigate the effects of PA‐MSHA (__Pseudomonas aeruginosa__‐mannose sensitive hemagglutinin) on inhibiting proliferation of breast cancer cell lines and to explore its mechanisms of action in human breast cancer cells. MCF‐10A, MCF‐7, MDA‐MB‐468, and MDA‐MB‐231HM cells were treate
Chlorpheniramine inhibits the synthesis of ornithine decarboxylase and the proliferation of human breast cancer cell lines
✍ Scribed by Miguel Angel Medina; Rocío García de Veas; Pilar Morata; José Lozano; Francisca Sánchez-Jiménez
- Publisher
- Springer US
- Year
- 1995
- Tongue
- English
- Weight
- 699 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Involvement of ornithine decarboxylase (ODC) in proliferation of the HT29 cell line and its control by either fetal calf serum (FCS) or vasoactive intestinal peptide (VIP) as an external signal increasing CAMP level were investigated. Activation of the polyamine-producing system appears to be a nece
## Abstract Arsenic trioxide (As~2~O~3~) is one of the arsenic compounds found in nature. As~2~O~3~ has recently been used to treat patients suffering from retinoic acid receptor (AML). It is of clinical interest to investigate whether As~2~O~3~ is also effective in treating solid tumors. Here, we
## Abstract Four different approaches were used to test a postulated relationship between ornithine decarboxylase (ODC) activity and L6 muscle cell proliferation. In the first approach, the level of ODC activity in myoblasts was compared to that of myotubes. The fusion of proliferating myoblasts to
## Abstract Breast cancer frequently metastasizes to the bone, often leading to the formation of osteolytic lesions. This work compares the paracrine‐induced osteoclastogenesis mediated by four human breast cancer cell lines, the estrogen‐receptor positive T47D and MCF‐7 and the estrogen‐negative S
Ebp1, an ErbB-3 binding protein, translocates from the cytoplasm to the nucleus of human breast cancer cells after treatment with the ErbB-3 ligand, heregulin. The purpose of these studies was to examine the effects of ectopic expression of ebp1 on the biological properties of human ErbB-3-expressin